SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001415889-14-001555
Filing Date
2014-05-16
Accepted
2014-05-16 17:22:01
Documents
3
Effectiveness Date
2014-05-16

Document Format Files

Seq Description Document Type Size
1 ectedefa14a2may162014.htm DEFA14A 90214
2 ectedefa14a2may1620140.jpg GRAPHIC 16349
3 ectedefa14a2may1620141.jpg GRAPHIC 7128
  Complete submission text file 0001415889-14-001555.txt   124215
Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103
Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35218 | Film No.: 14852496
SIC: 3845 Electromedical & Electrotherapeutic Apparatus